Nico.lab Pre IPO, page-15

4: sales network
Already partnering with the largest stroke treatment provider ($11 billion USD revenue ) . They see value in partnering with Nico because more identification of clots leads to more surgeries and more sale of their products. Also, large players such as Siemens, Toshiba would be open to reselling Nico as an add on. Considering the size of the hospital sector, potential is huge .